JINXIN FERTILITY GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.26 HKD | -4.24% |
|
-11.37% | -32.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jinxin Fertility Group Limited is a China-based company principally engaged in the provision of assisted reproductive services (ARS). The Company operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The Company mainly operates its business in China and the Unites.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.182
CNY
Average target price
4.184
CNY
Spread / Average Target
+91.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -32.54% | 831M | |
| -12.66% | 86.92B | |
| +19.19% | 85.34B | |
| +12.75% | 29.88B | |
| -10.55% | 17.1B | |
| -6.02% | 15.24B | |
| -6.70% | 14.29B | |
| +1.09% | 12.38B | |
| -30.70% | 12.1B | |
| +24.05% | 11.4B |
- Stock Market
- Equities
- 1951 Stock
- News Jinxin Fertility Group Limited
- Jinxin Fertility : Seeks $168 Million from Private Placement to Fund M&As
